Weiterhin gute Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen dritte Meilensteinzahlung von Pfizer in diesem Jahr für diese…
Allschwil, Switzerland, November 20, 2023…
…
Viatris is the old generic drug company Mylan, acquired by Pfizer and merged with its Upjohn division. The stock has…
Both companies share prices have slipped recently.…
Both companies share prices have slipped recently.…
Though Pfizers (PFE) revenues from COVID products are declining sharply, the launch of some key non-COVID products in 2023 is…
Despite little prescriber differentiation between the JAKs, including satisfaction and manufacturer perceptions, Olumiant is projected to maintain a significant market…
Pfizer Inc (NYSE:PFE) has said it will lay off more than half of its employees at a UK-based scientific research centre…
…
…
Pfizer is cutting 500 jobs at its Sandwich, Kent site in the U.K. as part of a cost-cutting effort, Sky…
Pfizer to cut 500 jobs at Kent site - Sky News…
One is growing now, and the other will grow soon.…
Todays Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Walmart Inc. (WMT) and…
Excluding a brief early 2020 plunge, Pfizer shares are now trading at their lowest level since 2016.…
Prior to launch, prescribers estimate that TNF inhibitors are likely to bear the greatest brunt of increased adoption of the…
Am Freitag noch im Rally-Modus, zum Wochenauftakt an der Seitenlinie: Die US-Investoren üben sich am Montag in Zurückhaltung. In der…
Analysts said upcoming data on Pfizers obesity pill, danuglipron, will be crucial to how competitive the company can be against…
Calgary (www.aktiencheck.de, Anzeige)
Einschätzung
Strong OutperformerKurszieleKursziel 12M: 9 USD
Kurschance: 223%
Kursziel 24M: 13,50 USD
Kurschance: 384%StammdatenISIN: CA98420Q3061
WKN: A3EUNZ
Ticker: ANUA
TSXV: XRTX.V
NASDAQ: XRTXKursdatenKurs: 2,79 USD
52W Hoch:…
…
By John Vandermosten, CFA
NASDAQ:ACHV
READ THE FULL ACHV RESEARCH REPORT
Achieve Life Sciences, Inc. (NASDAQ:ACHV) reported third quarter 2023 results in a…
…
Pfizer, Eli Lilly, General Motors and Tesla have been highlighted in this Earnings Trends article.…
Pfizer works to speed production of key penicillin as officials see "unacceptable American crisis," underscoring need for rapid testing and…
…
By John Vandermosten, CFA
NYSE:PLX
READ THE FULL PLX RESEARCH REPORT
Third Quarter 2023 Financial and Operational Review
Protalix Biotherapeutics, Inc. (NYSE:PLX) announced 3Q:23…
…
MAINZ (dpa-AFX) - Das Biotechnologieunternehmen Biontech hat wie andere Hersteller mit dem schrumpfenden Absatz von Covid-19-Impfstoffen zu kämpfen. Die…
BioNTech SE’s stock BNTX rallied premarket after the company posted a surprise profit for the third quarter and revenue that…
Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in…
Derzeit gibt es in der Pharma- und Biotechbranche große Verlierer unter den Unternehmen, welche die größten Profiteure der Corona Krise…
Tokyo, Japan and Cambridge, UK, 06 November 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) has…
The old adage is that magazine covers are a jinx. That’s particularly true with The Economist but Barron’s has had…
London (www.aktiencheck.de) - Rating-Update:
Die Analysten von Barclays stufen die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol:…
…
Its important to look at Pfizer through a long-term lens.…
Its important to look at Pfizer through a long-term lens.…
…
New York/Frankfurt (Reuters) - Der US-Biotechkonzern Moderna kappt wegen der schwachen Nachfrage die Umsatzerwartungen für seinen Covid-19-Impfstoff.
Für 2023 rechnet…
…
Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say…
A $5.6 billion inventory write-down isnt what investors wanted to see, but this company is made of many moving pieces.…
A $5.6 billion inventory write-down isnt what investors wanted to see, but this company is made of many moving pieces.…
Moderna should hit the lower end of its sales target for this year as it only needs to tap a…
Calgary (www.aktiencheck.de, Anzeige)
Einschätzung
Strong OutperformerKurszieleKursziel 12M: 1,00 EUR
Kurschance: 234%
Kursziel 24M: 1,50 EUR
Kurschance: 402%StammdatenISIN: CA98420Q2071
WKN: A3C9TS
Ticker: ANU
TSXV: XRTX.V
NASDAQ: XRTXKursdatenKurs: 0,299 EUR
52W Hoch:…
Scarlet Fu and Katie Greifeld bring you the latest news and analysis leading up to the final minutes and seconds…
ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat die Einstufung für Pfizer nach Zahlen zum dritten Quartal auf "Neutral"…
ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat die Einstufung
für Pfizer nach Zahlen zum dritten Quartal auf "Neutral" mit…
PFE earnings call for the period ending September 30, 2023.…